Atalanta Therapeutics Raises $97M To Advance RNAi Therapies For CNS
28 Jan 2025 //
BUSINESSWIRE
EQT Lead 75 M Series B in Atalanta for Epilepsy, Huntington Disease
28 Jan 2025 //
PR NEWSWIRE
Atalanta Expands Exec Team With CMO, CFO Appointments
22 May 2024 //
BUSINESSWIRE
Atalanta Tx Appoints Alfred Sandrock to Board of Directors
10 Mar 2022 //
BUSINESSWIRE